A Nonrandomized, Open-Label, Multicenter, Phase 4 Pilot Study on the Effect and Safety of ILUVIEN® in Chronic Diabetic Macular Edema Patients Considered Insufficiently Responsive to Available Therapies (RESPOND)

João Figueira,José Fernando Castanha Henriques,M. Amaro,Rosas,Dalila Alves,José Cunha-Vaz

A Nonrandomized, Open-Label, Multicenter, Phase 4 Pilot Study on the Effect and Safety of ILUVIEN® in Chronic Diabetic Macular Edema Patients Considered Insufficiently Responsive to Available Therapies (RESPOND)

2017

João Figueira
José Fernando Castanha Henriques
M. Amaro
Rosas
Dalila Alves
José Cunha-Vaz

Purpose: The aim of this study was to assess the effectiveness and safety of ILUVIEN® in patients with chronic diabetic macular edema (DME) who were insufficientl

Keywords:

Ophthalmology
Diabetes mellitus
Intravitreal implant
Visual acuity
Macular edema
Medicine
Anatomy
open label
diabetic macular edema
after treatment
Internal medicine
Intraocular pressure
Demographics

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations